ECSP088994A - INHIBIDORES DE CANAL DE POTASIO Kv1.5 - Google Patents

INHIBIDORES DE CANAL DE POTASIO Kv1.5

Info

Publication number
ECSP088994A
ECSP088994A EC2008008994A ECSP088994A ECSP088994A EC SP088994 A ECSP088994 A EC SP088994A EC 2008008994 A EC2008008994 A EC 2008008994A EC SP088994 A ECSP088994 A EC SP088994A EC SP088994 A ECSP088994 A EC SP088994A
Authority
EC
Ecuador
Prior art keywords
potassium channel
channel inhibitors
present
imidazolidinones
derivatives
Prior art date
Application number
EC2008008994A
Other languages
English (en)
Spanish (es)
Inventor
Anusz John Michael Janusz
Stephen Joseph Hodson
Gregory Kent Bosch
Ronald Eugene White
Benjamin E Blass
Christopher M Jackson
Neil T Fairweather
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP088994A publication Critical patent/ECSP088994A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EC2008008994A 2006-06-20 2008-12-19 INHIBIDORES DE CANAL DE POTASIO Kv1.5 ECSP088994A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81509106P 2006-06-20 2006-06-20

Publications (1)

Publication Number Publication Date
ECSP088994A true ECSP088994A (es) 2009-01-30

Family

ID=38582320

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008994A ECSP088994A (es) 2006-06-20 2008-12-19 INHIBIDORES DE CANAL DE POTASIO Kv1.5

Country Status (20)

Country Link
US (2) US7504517B2 (enExample)
EP (1) EP2035392A1 (enExample)
JP (1) JP2009541343A (enExample)
KR (1) KR20090021223A (enExample)
CN (1) CN101573341A (enExample)
AR (1) AR061523A1 (enExample)
AU (1) AU2007260985A1 (enExample)
BR (1) BRPI0713320A2 (enExample)
CA (1) CA2655574A1 (enExample)
CL (1) CL2007001794A1 (enExample)
CO (1) CO6150173A2 (enExample)
CR (1) CR10527A (enExample)
EC (1) ECSP088994A (enExample)
MX (1) MX2008016399A (enExample)
NO (1) NO20085252L (enExample)
PE (1) PE20080942A1 (enExample)
RU (1) RU2008150465A (enExample)
TW (1) TW200815363A (enExample)
WO (1) WO2007149874A1 (enExample)
ZA (1) ZA200810763B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101573341A (zh) * 2006-06-20 2009-11-04 惠氏公司 咪唑烷酮Kv1.5钾通道抑制剂
RU2373934C1 (ru) * 2008-03-19 2009-11-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
CN101544580B (zh) * 2009-04-28 2019-03-15 大连凯飞精细化工有限公司 R-alpha-氨基-4-甲氧基苯乙酰胺的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4099009A (en) * 1977-04-11 1978-07-04 Morton-Norwick Products, Inc. 1-(4-chlorophenyl)-3-(1-ureido)-2-imidazolidinone
SK94393A3 (en) 1992-09-11 1994-08-10 Thomae Gmbh Dr K Cyclic derivatives of urea, process for their production and their pharmaceutical agents with the content of those
DE4332168A1 (de) 1993-02-22 1995-03-23 Thomae Gmbh Dr K Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
JP2000501111A (ja) 1996-01-26 2000-02-02 バーテックス ファーマシューティカルズ インコーポレイテッド アスパルチルプロテアーゼインヒビター
JP2000507581A (ja) 1996-04-03 2000-06-20 メルク エンド カンパニー インコーポレーテッド ファルネシル―タンパク質転移酵素の阻害剤
US7129359B2 (en) 2002-07-09 2006-10-31 National Health Research Institutes Imidazolidinone compounds
CN1582279A (zh) 2001-11-30 2005-02-16 伊莱利利公司 过氧化物酶体激活的受体激动剂
US7189856B2 (en) 2001-12-28 2007-03-13 Gideon Shapiro Non-peptide somatostatin receptor ligands
AU2003302027A1 (en) 2002-11-21 2004-06-15 Vicore Pharma Ab New tricyclic angiotensin ii agonists
JP2004262903A (ja) 2003-03-04 2004-09-24 Japan Science & Technology Agency アジリジン類の製造方法
US7259174B2 (en) 2004-05-25 2007-08-21 National Health Research Institutes Imidazolidinone compounds
WO2006027211A1 (en) * 2004-09-07 2006-03-16 Glaxo Group Limited 2,4-substituted pyrimidines as cysteine protease inhibitors
KR100677149B1 (ko) 2004-11-12 2007-02-02 삼성전자주식회사 잉크 조성물
CN101573341A (zh) * 2006-06-20 2009-11-04 惠氏公司 咪唑烷酮Kv1.5钾通道抑制剂

Also Published As

Publication number Publication date
US7803827B2 (en) 2010-09-28
EP2035392A1 (en) 2009-03-18
US20070299120A1 (en) 2007-12-27
TW200815363A (en) 2008-04-01
WO2007149874A1 (en) 2007-12-27
US20090069342A1 (en) 2009-03-12
JP2009541343A (ja) 2009-11-26
CN101573341A (zh) 2009-11-04
ZA200810763B (en) 2009-09-30
PE20080942A1 (es) 2008-09-03
WO2007149874A8 (en) 2008-03-20
AU2007260985A1 (en) 2007-12-27
KR20090021223A (ko) 2009-02-27
CA2655574A1 (en) 2007-12-27
MX2008016399A (es) 2009-02-03
RU2008150465A (ru) 2010-07-27
AR061523A1 (es) 2008-09-03
BRPI0713320A2 (pt) 2012-02-07
NO20085252L (no) 2009-01-13
CL2007001794A1 (es) 2008-01-18
US7504517B2 (en) 2009-03-17
CR10527A (es) 2009-02-19
CO6150173A2 (es) 2010-04-20

Similar Documents

Publication Publication Date Title
BRPI0818672A2 (pt) 2'-fluor-2'-desoxitetra-hidrouridinas como inibidores da citidina desaminase
ECSP11010798A (es) 1,2,5-oxadiazoles como inhibidores de indolamina 2,3-dioxigenasa
NO20082298L (no) Kaliumkanalinhibitorer
CU20070160A7 (es) Pirrolopirazoles, inhibidores potentes de quinasa
CO6361894A2 (es) Composiciones aclaradoras de la piel con inhibidores de acetilcolinesterasa
MX2009011002A (es) Composiciones de proteccion de isquemia/reperfusion y metodos de uso.
PA8650801A1 (es) Composiciones y formulaciones de ecteinascidina, como la ecteinascidina 743
CR11731A (es) Composiciones y procedimientos para su preparación y uso
PA8842101A1 (es) Heteroarilos sustituidos
ATE461990T1 (de) Zusammensetzung für die gewebepflege
BRPI0513310A (pt) análogos de tetrapeptìdeo
GT200800158A (es) Pirazolquinolonas como potentes inhibidores de parp
TR201818983T4 (tr) İnflamatuvar Cilt Bozukluklarının Tedavisine Yönelik Olarak Sübstitüe Edilmiş Tetrasiklin Bileşikleri
CO2022000481A2 (es) Inhibidores de enzimas
PA8667201A1 (es) Nuevos compuestos farmaceuticos
EA201071369A1 (ru) Композиции для лечения выпадения волос
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
MX2021009142A (es) Inhibidores topicos de fosfoinositol 3-cinasas.
DE602004028493D1 (de) Isochinolinon-kaliumkanalinhibitoren
ECSP088994A (es) INHIBIDORES DE CANAL DE POTASIO Kv1.5
NI201100035A (es) Agentes antifúngicos.
BR112012008680A2 (pt) composição para cuidado oral, e, método para tratar ou prevenir mau odor oral
CL2004000713A1 (es) Compuestos de 7-alquinilamino-triazolopirimidinas; procedimiento de preparacion; composicion que los contiene, utiles para combatir hongos fitopatogenos.
MX2010006926A (es) 4-imidazolidinonas como inhibidores del canal de potasio kv1.5.
ECSP077208A (es) Inhibidores de los canales de potasio